GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma

Figure 8

Construction of risk score model derived from GPR176-associated immunomodulators. (a) Univariate regression analysis of GPR176-related immunomodulators on STAD prognosis. (b) Multivariate regression analysis of GPR176-related immunomodulators on STAD prognosis. (c) OS comparison between high- and low-risk cohorts. (d) Distribution plot of immune checkpoints in high- and low-risk cohorts. (e) Distribution plot of survival status of patients according to risk score ranking. (f) Risk score ranking for high- and low-risk patients.

(a)

(b)

(c)

(d)

(e)

(f)